Chemed (CHE) vs Option Care Health (OPCH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Chemed (CHE) has outperformed Option Care Health (OPCH) over the past year, gaining 14.6% versus a gain of 14.2%. Over five years, OPCH leads with a +26.9% price change compared with +15.8% for CHE. Chemed is the larger company by market cap ($6.51 billion vs $4.65 billion), about 1.4 times the size, while Option Care Health is growing revenue faster (+13.0% vs +4.1%).
On valuation, Option Care Health trades at a lower forward P/E (14.9x vs 18.1x for Chemed). Chemed pays a dividend yielding 0.48%, while Option Care Health does not currently pay one. Chemed converts more of its revenue into profit, with a net margin of 10.5% versus 3.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CHE | OPCH |
|---|---|---|
| Share price | $498.25 | $31.05 |
| Market cap | $6.51B | $4.65B |
| 1-day change | -0.64% | +0.13% |
| YTD return | +16.45% | -2.54% |
| 1-year return | +14.55% | +14.20% |
| 5-year return | +15.84% | +26.94% |
| P/E ratio (TTM) | 25.06 | 23.52 |
| Forward P/E | 18.11 | 14.91 |
| EPS (TTM) | $19.88 | $1.32 |
| Dividend yield | 0.48% | 0.00% |
| Annual dividend | $2.40 | $0.00 |
| Revenue (latest FY) | $2.53B | $5.65B |
| Revenue growth (YoY) | +4.06% | +13.03% |
| Net income (latest FY) | $265.24M | $207.59M |
| Gross margin | 32.54% | 19.26% |
| Operating margin | 13.37% | 5.98% |
| Net margin | 10.48% | 3.67% |
| 52-week high | $557.00 | $36.80 |
| 52-week low | $365.21 | $18.01 |
| Distance from 52-week high | -10.55% | -15.62% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +14.72% | -1.19% |
| Average volume | 159.85K | 3.57M |
| Shares outstanding | 13.07M | 149.79M |
| Employees | 15,811 | 8,000 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Chemed is more profitable, keeping 10.5 cents of every revenue dollar as net income versus 3.7 cents for Option Care Health.
- Option Care Health grew revenue faster in its latest fiscal year (+13.03% vs +4.06%).
About Chemed
CHE stock →Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments.
Health Care · Medical/Nursing Services · 15,811 employees
About Option Care Health
OPCH stock →Option Care Health, Inc. offers home and alternate site infusion services in the United States.
Health Care · Medical/Nursing Services · 8,000 employees
CHE vs OPCH FAQ
Which is bigger, Chemed or Option Care Health?
Chemed (CHE) is larger, with a market capitalization of $6.51B compared with $4.65B for Option Care Health (OPCH).
Which stock has performed better over the past year, CHE or OPCH?
CHE returned +14.55% over the past 12 months, compared with +14.20% for OPCH (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CHE or OPCH?
OPCH has the lower trailing P/E at 23.5, versus 25.1 for CHE. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Chemed or Option Care Health?
Chemed pays a dividend yielding 0.48%, while Option Care Health does not currently pay a regular dividend.
Are Chemed and Option Care Health in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.